Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Helicobacter pylori infection and colorectal cancer risk: evidence from a large population-based case-control study in Germany.
Zhang Y, Hoffmeister M, Weck MN, Chang-Claude J, Brenner H.
Am J Epidemiol. 2012 Mar 1;175(5):441-50. Epub 2012 Jan 31.
Related citations
Reported intake of selected micronutrients and risk of colorectal cancer: results from a large population-based case-control study in Newfoundland, Labrador and Ontario, Canada.
Sun Z, Zhu Y, Wang PP, Roebothan B, Zhao J, Zhao J, Dicks E, Cotterchio M, Buehler S, Campbell PT, McLaughlin JR, Parfrey PS.
Anticancer Res. 2012 Feb;32(2):687-96.
The expression of MAGE and SSX, and correlation of COX2, VEGF, and survivin in colorectal cancer.
Choi J, Chang H.
Anticancer Res. 2012 Feb;32(2):559-64.
Anticipating implementation of colorectal cancer screening in The Netherlands: a nation wide survey on endoscopic supply and demand.
van Turenhout ST, Terhaar sive Droste JS, Meijer GA, Masclée AA, Mulder CJ.
BMC Cancer. 2012 Jan 26;12:46.
Identification of a biomarker panel for colorectal cancer diagnosis.
García-Bilbao A, Armañanzas R, Ispizua Z, Calvo B, Alonso-Varona A, Inza I, Larrañaga P, López-Vivanco G, Suárez-Merino B, Betanzos M.
BMC Cancer. 2012 Jan 26;12:43.
Double sampling of a faecal immunochemical test is not superior to single sampling for detection of colorectal neoplasia: a colonoscopy controlled prospective cohort study.
Oort FA, van Turenhout ST, Coupé VM, van der Hulst RW, Wesdorp EI, Terhaar sive Droste JS, Larbi IB, Kanis SL, van Hengel E, Bouman AA, Meijer GA, Mulder CJ.
BMC Cancer. 2011 Oct 10;11:434.
Role of protein kinase C and epidermal growth factor receptor signalling in growth stimulation by neurotensin in colon carcinoma cells.
Müller KM, Tveteraas IH, Aasrum M, Ødegård J, Dawood M, Dajani O, Christoffersen T, Sandnes DL.
BMC Cancer. 2011 Oct 2;11:421.
P53 suppresses expression of the 14-3-3 gamma oncogene.
Radhakrishnan VM, Putnam CW, Qi W, Martinez JD.
BMC Cancer. 2011 Aug 25;11:378.
9. Cancers attributable to inadequate physical exercise in the UK in 2010.
Parkin DM.
Br J Cancer. 2011 Dec 6;105 Suppl 2:S38-41. doi: 10.1038/bjc.2011.482. No abstract available.
6. Cancers attributable to dietary factors in the UK in 2010. III. Low consumption of fibre.
Parkin DM, Boyd L.
Br J Cancer. 2011 Dec 6;105 Suppl 2:S27-30. doi: 10.1038/bjc.2011.479. No abstract available.
5. Cancers attributable to dietary factors in the UK in 2010. II. Meat consumption.
Br J Cancer. 2011 Dec 6;105 Suppl 2:S24-26. doi: 10.1038/bjc.2011.478. No abstract available.
Incidence, prevalence and risk factors for peritoneal carcinomatosis from colorectal cancer.
Segelman J, Granath F, Holm T, Machado M, Mahteme H, Martling A.
Br J Surg. 2012 May;99(5):699-705. doi: 10.1002/bjs.8679. Epub 2012 Jan 27.
Comparison of adverse events during 5-fluorouracil versus 5-fluorouracil/oxaliplatin adjuvant chemotherapy for stage III colon cancer: A Population-based analysis.
Sanoff HK, Carpenter WR, Freburger J, Li L, Chen K, Zullig LL, Goldberg RM, Schymura MJ, Schrag D.
Cancer. 2012 Jan 31. doi: 10.1002/cncr.27422. [Epub ahead of print]
Identification of candidate genes carrying polymorphisms associated with the risk of colorectal cancer by analyzing the colorectal mutome and microRNAome.
Landi D, Gemignani F, Pardini B, Naccarati A, Garritano S, Vodicka P, Vodickova L, Canzian F, Novotny J, Barale R, Landi S.
Cancer. 2012 Jan 26. doi: 10.1002/cncr.27435. [Epub ahead of print]
3'-UTR and functional secretor haplotypes in mannose-binding lectin 2 are associated with increased colon cancer risk in African Americans.
Zanetti KA, Haznadar M, Welsh JA, Robles AI, Ryan BM, McClary AC, Bowman ED, Goodman JE, Bernig T, Chanock SJ, Harris CC.
Cancer Res. 2012 Mar 15;72(6):1467-77. Epub 2012 Jan 26.
Tumor-derived chemokine CCL5 enhances TGF-β-mediated killing of CD8(+) T cells in colon cancer by T-regulatory cells.
Chang LY, Lin YC, Mahalingam J, Huang CT, Chen TW, Kang CW, Peng HM, Chu YY, Chiang JM, Dutta A, Day YJ, Chen TC, Yeh CT, Lin CY.
Cancer Res. 2012 Mar 1;72(5):1092-102. Epub 2012 Jan 26.
Correlation between gene expression of IGF-1R pathway markers and cetuximab benefit in metastatic colorectal cancer.
Huang F, Xu LA, Khambata-Ford S.
Clin Cancer Res. 2012 Feb 15;18(4):1156-66. Epub 2012 Jan 31.
Relationship between 18F-fluorodeoxyglucose accumulation and KRAS/BRAF mutations in colorectal cancer.
Kawada K, Nakamoto Y, Kawada M, Hida K, Matsumoto T, Murakami T, Hasegawa S, Togashi K, Sakai Y.
Clin Cancer Res. 2012 Mar 15;18(6):1696-703. Epub 2012 Jan 26.
Colorectal cancers with microsatellite instability display unique miRNA profiles.
Balaguer F, Moreira L, Lozano JJ, Link A, Ramirez G, Shen Y, Cuatrecasas M, Arnold M, Meltzer SJ, Syngal S, Stoffel E, Jover R, Llor X, Castells A, Boland CR, Gironella M, Goel A.
Clin Cancer Res. 2011 Oct 1;17(19):6239-49. Epub 2011 Aug 15.
Pre-operative bevacizumab, capecitabine, oxaliplatin and radiation among patients with locally advanced or low rectal cancer: a phase II trial.
Kennecke H, Berry S, Wong R, Zhou C, Tankel K, Easaw J, Rao S, Post J, Hay J.
Eur J Cancer. 2012 Jan;48(1):37-45. Epub 2011 Jun 12.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on